Celularity Signs Exclusive U.S. Peptide API Manufacturing Collaboration

Celularity and Vesalius will establish U.S.-based final-stage manufacturing for Peptual peptide APIs at Celularity’s Florham Park facility, excluding GLP-1s. Commercial supply is subject to cGMP qualification and potential FDA compounding policies.